openPR Logo
Press release

Chinese Medical Team Achieves Functional Cure in 24 Cases of Type 1 Diabetes Mellitus (T1DM) Using Holistic Integrative Medicine (HIM)

08-15-2025 06:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: SHENZHEN HMEDIUM INFORMATION TECHNOLOGY CO.,LTD
Chinese Medical Team Achieves Functional Cure in 24 Cases of Type

Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 diabetes mellitus (T1DM) discontinue insulin therapy through holistic integrative medicine (HIM)-an optimized combination of traditional Chinese and Western medicine-thereby achieving a functional cure. The longest duration of insulin discontinuation has reached 14 months. This breakthrough offers new hope for global T1DM treatment and marks a remarkable advance in integrated Chinese and Western medicine for autoimmune diseases..

Breakthrough Therapy: Precision Intervention through HIM

T1DM is an autoimmune disorder characterized by the destruction of beta cells, resulting in an absolute deficiency of insulin secretion. Conventional medicine holds that patients require lifelong insulin injections. However, Professor An's team employed the HIM model combining holistic traditional Chinese medicine (TCM), orthomolecular medicine, functional medicine, and lifestyle medicine focused on immune blockade and metabolic balance, alongside endocrinology-specialized precision remote digital healthcare, to successfully restore islet function and enable insulin discontinuation.

The core of this treatment protocol lies in multidisciplinary collaboration, including precision diagnostics using mass spectrometry platforms to identify the immunological causes of T1DM for targeted etiological treatment; immune regulation through molecular nutrition and TCM to modulate abnormal immune responses and reduce autoimmune attacks on pancreatic islet cells; metabolic repair by improving the body's microenvironment and promoting islet function recovery via TCM acupuncture, herbal medicine, and nutritional interventions; and precision monitoring that employs artificial intelligence to dynamically analyze patients' blood glucose and immune markers, allowing personalized adjustments to treatment strategies. Patients typically require only 3 to 5 days of hospitalization before discharge.

Image: https://www.globalnewslines.com/uploads/2025/08/fb183cb053d458025cfc49891d151061.jpg

(Professor An Chiying inspects patients with type 1 diabetes)

Clinical Data: 24 Patients Discontinued Insulin Therapy

Over a two-year clinical observation period, the team intervened in 70 patients with T1DM, among whom 24 patients (34%) completely discontinued insulin use. These patients maintained stable blood glucose levels (HbA1c < 7%) and showed significant recovery of islet function as evidenced by C-peptide testing. Currently, these patients only require dietary management and regular follow-up, without reliance on exogenous insulin.

Professor An Chiying emphasized, "Functional cure refers to the partial restoration of islet function sufficient to meet normal metabolic demands, achieved through immune blockade, intestinal mucosal repair, and gut microbiota reconstruction. Patients diagnosed early with T1DM who have a C-peptide level above 0.5 ng/ml can stop insulin, while those with insufficient islet function can significantly reduce insulin dosage once blood glucose levels are stabilized."

National Academician's Evaluation: Pioneering a New Treatment Paradigm

Academician Fan Daiming of the Chinese Academy of Engineering (CAE) and pioneer of HIM in China commented, "The results achieved by this Chinese team challenge the traditional view that T1DM requires lifelong medication. The synergistic effects of HIM deserve the attention of peers worldwide and open a new clinical treatment paradigm for T1DM."

Background

There are approximately 9 million T1DM patients globally. Traditional treatment costs exceed RMB 10,000 annually, and patient prognoses remain unsatisfactory with uncontrollable risks of complications. The widespread adoption of HIM health management programs could significantly reduce both the financial and health burdens on patients.

Shenzhen Hengsheng Hospital Chronic Disease Integrative Medicine Center/Diabetes Naturopathic Center
Media Contact
Company Name: ShanghaiFosunGroup-ShenzhenHangSengHospital
Contact Person: Anchiying
Email: Send Email [http://www.universalpressrelease.com/?pr=chinese-medical-team-achieves-functional-cure-in-24-cases-of-type-1-diabetes-mellitus-t1dm-using-holistic-integrative-medicine-him]
Phone: +86-755-27796031
City: Shenzhen
Country: China
Website: https://www.hsyy.com.cn/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chinese Medical Team Achieves Functional Cure in 24 Cases of Type 1 Diabetes Mellitus (T1DM) Using Holistic Integrative Medicine (HIM) here

News-ID: 4146498 • Views:

More Releases from Getnews

RGC Hoisting Introduces Next-Generation PHD Ladder Hoists for Safer, More Efficient Job Sites
RGC Hoisting Introduces Next-Generation PHD Ladder Hoists for Safer, More Effici …
Buffalo, NY - September 8, 2025 - RGC Hoisting, a manufacturer of professional-grade lifting solutions for over 75 years, has launched its new line of PHD Ladder Hoists. The product line includes three models: the PHD 250, PHD 400, and PHD 400 pivoting. Each one is designed to address the growing need for safer and more efficient equipment in the roofing and construction industries, where workers regularly face risks associated
Brilliant Registered Expands Service Offerings to Include Additional Specialties
Brilliant Registered Expands Service Offerings to Include Additional Specialties
Image: https://www.globalnewslines.com/uploads/2025/09/1757022440.jpg Chicago, IL - September 8, 2025 - Brilliant [https://brilliantfs.com/]announces the expansion of its service offerings beyond accounting, finance, and technology to meet the growing demand for talent in a broader range of business functions. Brilliant now offers contract, contract-to-hire, and direct-hire staffing solutions through its Business Operations Staffing [https://brilliantfs.com/how-we-help/business-operations-staffing/] division, focusing on the following areas: * Human Resources * Talent Acquisition * Supply Chain * Procurement * Logistics *
Inclusive Shapewear Defines CYSM's Growing Sisterhood of Support
Inclusive Shapewear Defines CYSM's Growing Sisterhood of Support
CYSM is a shapewear brand where women empower one another through supportive fashion, shared confidence, and collective strength. Rooted in community, the brand represents women helping women and celebrates diversity through inclusive shapewear, inviting every woman to feel supported, distinguished, and inspired in her journey. Image: https://www.globalnewslines.com/uploads/2025/08/5b5eac2a2dc61e9e461146b44631fbd9.jpg Video: https://www.youtube.com/embed/P68sQXzeDAo?si=yhTpt7xfMkSYH2kC The idea of shaping up has always carried many meanings, but at CYSM, it has grown into something more than a conversation about appearance.
CYSM Shapers Showcases New Shapewear Lineup to Usher in a New Era for Women Embracing Themselves Fully
CYSM Shapers Showcases New Shapewear Lineup to Usher in a New Era for Women Embr …
CYSM Shapers is a US-based manufacturer of shapewear products with over 30 years of industry presence and innovation. Image: https://www.globalnewslines.com/uploads/2025/08/968e474fb1ca1f30808973da2a19cd2c.jpg While showcasing the latest editions to its Fajas Collection [https://cysm.com/collections/best-body-shaper-hourglass-figure], the team behind CYSM Shapers [https://www.cysm.com] has expressed great pride after their products have helped thousands of women nationwide in embracing curves, boosting their body confidence and self-image. CYSM is a company with over 30 years of operating experience. They are known for

All 5 Releases


More Releases for T1DM

Chinese Medical Team Achieves Functional Cure in Twenty-Four Cases of Type 1 Dia …
Shenzhen - August 18, 2025 - Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 diabetes mellitus (T1DM) discontinue insulin therapy through holistic integrative medicine (HIM)-an optimized combination of traditional Chinese and Western medicine-thereby achieving a functional cure. The longest duration of insulin discontinuation has reached 14 months. This breakthrough
Inclusion of Type 1 Diabetes Mellitus (T1DM) in National NCD Programme
13th August 2024, 10:00 am: People to People Health Foundation, in collaboration with DEESHA (Diabetes [Type 1] Education & Empowerment Strategic Health Alliance), hosted a pivotal roundtable discussion. under the esteemed guidance of the. This significant event marked a major step forward in the national health agenda, focusing on the critical inclusion of Type 1 Diabetes Mellitus (T1DM) in the National Non-Communicable Diseases (NCD) Programme. The roundtable brought together over
PolTREG has presented an innovative method for the treatment of type 1 diabetes …
Researchers from the Polish Consortium PolTREG and STRATEGMED TREGS presented the initial results of phase II trial assessing regulatory T cells (Tregs) during the 80th Conference of the American Diabetes Association (ADA). The Polish company operates in the same area as the American company Provention Bio, which has presented a method for the treatment of presymptomatic patients with type 1 diabetes mellitus (T1DM) during the same event. The American company’s
Recent Study on Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets …
Researchmoz added Most up-to-date research on "Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations" to its huge collection of research reports. Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a destruction or failure of insulin-secreting pancreatic beta cells, usually as a result of an autoimmune response. The resulting insulin deficiency
Type 1 Diabetes Mellitus - Heat Map and Analysis
Albany, NY, Feb 27, 2017: Type I diabetes mellitus (T1DM) is a metabolic disease characterized by chronic hyperglycemia, and is caused by defective insulin secretion by pancreatic beta cells. Under normal circumstances these cells would secrete insulin into the blood stream, which facilitates the uptake of glucose by target cells for metabolism, subsequently lowering blood glucose levels. The disease typically has childhood onset and patients cannot survive without pharmacotherapy, which
Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innov …
ResearchMoz added Latest Research Report titled " Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations " to it's Large Report database. Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a destruction or failure of insulin-secreting pancreatic beta cells, usually as a result of an autoimmune response. The resulting insulin deficiency